| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| hydroxychloroquine | angiotensin-converting enzyme 2 | small molecule | NA | drugbank | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | modulator |
| hydroxychloroquine | angiotensin-converting enzyme 2 | small molecule | NA | drugbank | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] Disease[MeSHID:D004194] |
NA | approved | modulator |
| hydroxychloroquine | toll-like receptor 7 | small molecule | Successful target | TTD , drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] Disease[MeSHID:D004194] |
2.89 | approved | antagonist |
| hydroxychloroquine | toll-like receptor 7 | small molecule | Successful target | TTD , drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.89 | approved | antagonist |
| hydroxychloroquine | toll-like receptor 9 | small molecule | NA | drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.45 | approved | antagonist |
| hydroxychloroquine | toll-like receptor 9 | small molecule | NA | drugbank , DGIDB | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] Disease[MeSHID:D004194] |
1.45 | approved | antagonist |
| hydroxychloroquine | dna | small molecule | NA | drugbank | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] Disease[MeSHID:D004194] |
NA | approved | cross-linking/alkylation |
| hydroxychloroquine | dna | small molecule | NA | drugbank | Rheumatoid Arthritis[MeSHID:D001172] Lupus Erythematosus Discoid[MeSHID:D008179] Malaria[MeSHID:D008288] Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | cross-linking/alkylation |
| click here to return to the previous page | ||||||||